E! 114899 ROBO-FISH BioReperia
| Reference number | |
| Coordinator | BioReperia AB |
| Funding from Vinnova | SEK 2 577 000 |
| Project duration | April 2021 - September 2024 |
| Status | Completed |
| Venture | Eurostars |
Important results from the project
The goals of the project were to develop and validate robots for automation of tumor implantation and visualization in zebrafish larvae. These objectives were fulfilled within the framework of the project. However, the robots need further development to be attractive in our production, and the project led to an understanding of the problems that need to be solved for this to happen. There is a plan for and a will to do this work even after the end of the project.
Expected long term effects
We expect that the results from the project, through further development and implementation in our production line, will lead to an increased scalability of our business. This is required to reach our business objectives and to make our precision medicine product as cost-efficient and high-quality as possible. Furthermore, this is also required to reach all the patients that our product can benefit, and thus for the societal (and personal) impact we expect our product to achieve in the future.
Approach and implementation
The robots were designed and produced through collaboration between LifeScienceMethods (LSM) and Confocal.nl. These robots were sent to and installed at our (BioReperia) and the other validation partners´ facilities. Each validation partner had specific tasks - BioReperia´s tasks were primarily to validate i.v. injection, implantation of patient material and application within immuno-oncology. However, we did some other injections as well. The validation was done in close collaboration with LSM.